Summary of clinical results
AVENE

Tolerability of use in pre-adolescents with mild to moderate facial acne
Tolerance in pre-adolescents
Population
16 subjects aged 9 to 11
64% girls, 44% boys
100% mild to moderate facial acne with at least 5 non-inflammatory lesions
Application of COMEDOMED+ intense anti-blemish treatment
Face application 2x/day for 21 days
Evaluation criteria
Dermatological controls
Results
Good skin tolerance
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.